Search research articles
Contact Us
Filters
Showing results (121-130 of 159) with videos related to
Page
of 16
Sort By:
Endocrinology
|
June 14, 2014
Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation
Gianluca Occhi, Daniela Regazzo, Nora Maria Albiger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 3, 2020
RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights
Guido Di Dalmazi, Barbara Altieri, Claus Scholz, et al.
Oncotarget
|
September 23, 2015
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC
Gianluca Occhi, Susi Barollo, Daniela Regazzo, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
January 8, 2026
Effect of cognitive training on cortisol levels in patients with neurocognitive disorders
Marina De Rui, Giulia Salerno Trapella, Chiara Ceolin, et al.
European Journal of Endocrinology
|
January 5, 2019
The natural history of autoimmune Addison's disease from the detection of autoantibodies to development of the disease: a long-term follow-up study on 143 patients
Lara Naletto, Anna Chiara Frigo, Filippo Ceccato, et al.
Journal of Personalized Medicine
|
April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
Vittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Journal of Clinical Medicine
|
November 6, 2019
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
Soraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
European Journal of Endocrinology
|
February 8, 2024
KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas
Fanny Chasseloup, Daniela Regazzo, Lucie Tosca, et al.
Endocrine Pathology
|
April 11, 2025
Multicentric Retrospective Analysis of Oncocytic Adrenocortical Carcinoma: Insights into Clinical and Management Strategies
Antonio Prinzi, Valentina Guarnotta, Guido Di Dalmazi, et al.
Cancers
|
April 5, 2020
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
Soraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 159) with videos related to
Sort By:
Page
of 16
Endocrinology
|
June 14, 2014
Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation
Gianluca Occhi, Daniela Regazzo, Nora Maria Albiger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 3, 2020
RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights
Guido Di Dalmazi, Barbara Altieri, Claus Scholz, et al.
Oncotarget
|
September 23, 2015
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC
Gianluca Occhi, Susi Barollo, Daniela Regazzo, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
January 8, 2026
Effect of cognitive training on cortisol levels in patients with neurocognitive disorders
Marina De Rui, Giulia Salerno Trapella, Chiara Ceolin, et al.
European Journal of Endocrinology
|
January 5, 2019
The natural history of autoimmune Addison's disease from the detection of autoantibodies to development of the disease: a long-term follow-up study on 143 patients
Lara Naletto, Anna Chiara Frigo, Filippo Ceccato, et al.
Journal of Personalized Medicine
|
April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
Vittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Journal of Clinical Medicine
|
November 6, 2019
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
Soraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
European Journal of Endocrinology
|
February 8, 2024
KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas
Fanny Chasseloup, Daniela Regazzo, Lucie Tosca, et al.
Endocrine Pathology
|
April 11, 2025
Multicentric Retrospective Analysis of Oncocytic Adrenocortical Carcinoma: Insights into Clinical and Management Strategies
Antonio Prinzi, Valentina Guarnotta, Guido Di Dalmazi, et al.
Cancers
|
April 5, 2020
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
Soraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
Page
of 16